(Q33815735)

29 July 2017

1 reference

title

Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

29 July 2017

main subject

0 references

inflammation

0 references

interstitial nephritis

1 reference

Corrigan G

1

1 reference

29 July 2017

Stevens PE

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

Alimentary Pharmacology & Therapeutics

29 July 2017

published in

1 reference

29 July 2017

volume

14

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-6

1 reference

Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

Tests of renal function in patients with quiescent colitis: effects of drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

Hypersensitivity to salicylazosulfapyridine: renal and hepatic toxic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

Nephrotic syndrome associated with sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

Mesalazine-associated interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

Mesalazine-associated interstitial nephritis: twice in the same patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

Mesalazine induced interstitial nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2000.00683.X

10.1046/J.1365-2036.2000.00683.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference